Cargando…
Enhancing anti-viral neutralization response to immunization with HIV-1 envelope glycoprotein immunogens
An effective human immunodeficiency virus type I (HIV-1) vaccine that robustly elicits broadly neutralizing antibodies (bnAbs) against HIV-1 envelope glycoproteins (Envs) to block viral entry is still not available. Thus, identifying triggers for elicitation of different types of anti-HIV-1 Env anti...
Autores principales: | Ahmed, Shamim, Parthasarathy, Durgadevi, Newhall, Rachael, Picard, Tashina, Aback, Morgainne, Ratnapriya, Sneha, Arndt, William, Vega-Rodriguez, Widaliz, Kirk, Natalie M., Liang, Yuying, Herschhorn, Alon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667240/ https://www.ncbi.nlm.nih.gov/pubmed/37996435 http://dx.doi.org/10.1038/s41541-023-00774-z |
Ejemplares similares
-
A Protocol for Studying HIV-1 Envelope Glycoprotein Function
por: Ratnapriya, Sneha, et al.
Publicado: (2020) -
Conformational flexibility of HIV-1 envelope glycoproteins modulates transmitted / founder sensitivity to broadly neutralizing antibodies
por: Ratnapriya, Sneha, et al.
Publicado: (2023) -
An entry-competent intermediate state of the HIV-1 envelope glycoproteins
por: Herschhorn, Alon, et al.
Publicado: (2017) -
A protocol for displaying viral envelope glycoproteins on the surface of vesicular stomatitis viruses
por: Farzani, Touraj Aligholipour, et al.
Publicado: (2020) -
A broad HIV-1 inhibitor blocks envelope glycoprotein transitions critical for entry
por: Herschhorn, Alon, et al.
Publicado: (2014)